Riskpilot← Back to searchSign inGet full accessReliqua AB
ABBankruptOrg 5568836802Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20120 employees
Revenue 2019
SEK 279K
+373% vs 2018
EBITDA margin
-6.1%
+73% vs 2018
Equity ratio
29.5%
Financial strength
Net profit 2019
SEK -80K
+18% vs 2018
| Revenue | SEK 279K | +373% |
| EBITDA | SEK -17K | +73% |
| Net profit | SEK -80K | +18% |
| Total assets | SEK 808K | -12% |
| Equity | SEK 238K | -25% |
| Employees | 0 | — |
Legal name
Reliqua AB
Org number
5568836802
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
8 februari 2012
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2019-12-31
Financial year
January – December
Signatory rights
Firman tecknas ensam av likvidatorn
Company purpose
Aktiebolaget ska bedriva uthyrning av friskvårdsprodukter samt därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 |
|---|---|---|---|---|---|
| Revenue | 828 | 978 | 449 | 59 | 279 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 223 | 275 | −12 | −62 | −17 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 223 | 275 | −12 | −62 | −17 |
| Net financials | −29 | −32 | −35 | −36 | −63 |
| Profit before tax | 194 | 195 | 1 | −98 | −80 |
| Tax | −0 | −32 | −3 | −0 | −0 |
| Net profit | 194 | 163 | −2 | −98 | −80 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 |
|---|---|---|---|---|---|
| Total assets | 959 | 901 | 920 | 922 | 808 |
| Equity | 255 | 418 | 416 | 318 | 238 |
| Long-term debt | 261 | 184 | 355 | 368 | 284 |
| Short-term debt | 443 | 251 | 149 | 236 | 286 |
| Total debt | 704 | 435 | 504 | 604 | 570 |
EBITDA margin
-6.1%
This company
15.8%
Market median
-139% vs market
20152019
Equity ratio
29.5%
This company
38.2%
Market median
-23% vs market
20152019
Return on equity
-33.6%
This company
18.4%
Market median
-283% vs market
20152019
Net profit margin
-28.7%
This company
8.1%
Market median
-454% vs market
20152019
Asset turnover
0.35×
This company
1.12×
Market median
-69% vs market
20152019
Debt / equity
2.39×
This company
0.62×
Market median
-285% vs market
20152019
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JM Liquidator | Liquidator | 2022 |
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
| Deputy Board Member | 2021 – 2022 | |
| Board of Directors | 2021 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Reliqua AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jens Magnus Nyström | Liquidator | 0 companies |
| Bo Greger Boström | Deputy Board Member | 0 companies |
| Jens Patrik Dehlin | Board of Directors | 0 companies |